Kimberly Clark Corp (KMB) · Nov 5, 2026 · Earnings
Beat — Adjusted EPS $1.70 vs published consensus near $1.60
Kimberly-Clark’s Q3 earnings beat expectations, but weak organic sales, margin pressure and China disruption temper the Kenvue-driven growth story.
Kimberly-Clark is midway through a major portfolio reset: it has completed the IFP divestiture, just closed the Kenvue acquisition, and is trying to use its Powering Care operating model to build a broader consumer-health platform. The Kenvue close and the quarter’s preliminary figures were already public before this final release, so the main new information is the completed detail and how the underlying business held up. The Kenvue transaction was completed on November 2, 2026, while the company had already said its preliminary third-quarter outlook was consistent with prior expectations.
The quarter cleared the earnings bar, but not because the core operating picture improved. Adjusted EPS from continuing operations was $1.70, above the published consensus near $1.60, while revenue of $4.134 billion was broadly around the roughly $4.1 billion expectation.
| Figure | Q3 2026 | Q3 2025 | Consensus |
|---|---|---|---|
| Net sales (Income Statement) | $4,134M (-0.4%) | $4,150M | ~$4,120M |
| Organic sales (Sales growth table) | -1.3% | — | — |
| Adjusted operating profit (Adjusted Operating Profit) | $677M (-0.9%) | $683M | — |
| Adjusted EPS—continuing operations (Adjusted EPS) | $1.70 (+17.2%) | $1.45 | ~$1.60 |
| NA operating profit (Segment results—NA) | $657M (+2.7%) | $640M | — |
| IPC operating profit (Segment results—IPC) | $144M (-32.7%) | $214M | — |
Underlying demand was soft, especially outside North America. Total organic sales fell 1.3%, with the China social-media disruption creating an approximately 270-basis-point headwind and retailer inventory movements adding pressure in North America. IPC organic sales fell 4.6%, and its operating profit plunged 32.7%, showing that the disruption and pricing pressure are hitting the international business rather than merely distorting reported comparisons. 〔0〕
Margins remain the weak spot despite productivity savings. Adjusted gross margin declined 130 basis points to 35.5%, while adjusted operating profit slipped 0.9% year over year. The company says productivity and lower marketing spending partly offset unfavorable pricing net of cost inflation and supply-chain investments, but the quarter still shows that its transformation is currently defending profitability more than expanding it. 〔1〕
The reported EPS surge is largely transaction accounting, not a step-change in the ongoing business. Reported diluted EPS was $5.37 because the completed IFP transaction generated a $1.4 billion gain; adjusted EPS attributable to Kimberly-Clark was $1.70, down from $1.82 a year earlier. The Kenvue acquisition also added $106 million of current-quarter operating charges, so the eventual integration benefits remain prospective rather than visible in this quarter’s results.
Management held the existing 2026 outlook, which limits the surprise. The company still expects organic sales growth to run about 100 basis points below category growth, adjusted operating profit to grow mid-single digits, continuing-operations adjusted EPS to grow high single digits, and attributable adjusted EPS to decline low single digits on a constant-currency basis. That is a reaffirmation, not an upgrade, and it leaves the market waiting for the Kenvue integration to offset weak organic growth and margin pressure. The outlook was previously described as consistent with prior expectations.
Bottom line: Kimberly-Clark beat the adjusted-EPS hurdle, but the core quarter was mixed: weak organic sales and shrinking margins were masked by tax effects and transaction-related items. The result keeps the Kenvue strategy on track, but does not yet prove that the larger company is executing better.
Kenvue integration update with fourth-quarter results
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!